185 related articles for article (PubMed ID: 36288156)
1. Molecular Characterization of CF33 Canine Cell Line and Evaluation of Its Ability to Respond against Infective Stressors in Sight of Anticancer Approaches.
Razzuoli E; De Ciucis CG; Chirullo B; Varello K; Zoccola R; Guardone L; Petrucci P; Rubini D; Bozzetta E; Goria M; Fruscione F; Modesto P
Vet Sci; 2022 Oct; 9(10):. PubMed ID: 36288156
[TBL] [Abstract][Full Text] [Related]
2. Animal models of Soft Tissue Sarcoma for alternative anticancer therapy studies: characterization of the A-72 Canine Cell Line.
Razzuoli E; Chirullo B; De Ciucis CG; Mecocci S; Martini I; Zoccola R; Campanella C; Varello K; Petrucci P; Di Meo A; Bozzetta E; Tarantino M; Goria M; Modesto P
Vet Res Commun; 2023 Sep; 47(3):1615-1627. PubMed ID: 37038001
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
Saito T; Tamura D; Asano R
Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782
[TBL] [Abstract][Full Text] [Related]
4. Characterization of D-17 Canine Osteosarcoma Cell Line and Evaluation of Its Ability to Response to Infective Stressor Used as Alternative Anticancer Therapy.
Modesto P; Fernandez JLC; Martini I; Zoccola R; Pugliano MC; Ciucis CG; Goria M; Ferrari A; Razzuoli E
Animals (Basel); 2020 Oct; 10(11):. PubMed ID: 33126659
[TBL] [Abstract][Full Text] [Related]
5. 4-methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells.
Saito T; Tamura D; Nakamura T; Makita Y; Ariyama H; Komiyama K; Yoshihara T; Asano R
Oncol Rep; 2013 Jan; 29(1):335-42. PubMed ID: 23124556
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis of canine mammary tumor cells induced by small interfering RNA (siRNA) against Bcl-xL gene.
Tsuchiya F; Kano R; Sano J; Oguma K; Hasegawa A
J Vet Med Sci; 2006 Nov; 68(11):1199-201. PubMed ID: 17146179
[TBL] [Abstract][Full Text] [Related]
7. Phylogenetic discordance of human and canine carcinoembryonic antigen (CEA, CEACAM) families, but striking identity of the CEA receptors will impact comparative oncology studies.
Weichselbaumer M; Willmann M; Reifinger M; Singer J; Bajna E; Sobanov Y; Mechtcherikova D; Selzer E; Thalhammer JG; Kammerer R; Jensen-Jarolim E
PLoS Curr; 2011 Mar; 3():RRN1223. PubMed ID: 21436956
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of small interfering RNA (siRNA) against the Mcl-1 gene in a canine mammary gland tumor cell line.
Kano R; Yano T; Nagamatsu K; Maruyama H; Kamata H; Hasegawa A
Res Vet Sci; 2009 Aug; 87(1):64-6. PubMed ID: 19185893
[TBL] [Abstract][Full Text] [Related]
9. Development of new therapy for canine mammary cancer with recombinant measles virus.
Shoji K; Yoneda M; Fujiyuki T; Amagai Y; Tanaka A; Matsuda A; Ogihara K; Naya Y; Ikeda F; Matsuda H; Sato H; Kai C
Mol Ther Oncolytics; 2016; 3():15022. PubMed ID: 27119113
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model.
Chaurasiya S; Yang A; Kang S; Lu J; Kim SI; Park AK; Sivanandam V; Zhang Z; Woo Y; Warner SG; Fong Y
Oncoimmunology; 2020; 9(1):1729300. PubMed ID: 32158622
[TBL] [Abstract][Full Text] [Related]
11. Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer.
Woo Y; Zhang Z; Yang A; Chaurasiya S; Park AK; Lu J; Kim SI; Warner SG; Von Hoff D; Fong Y
J Am Coll Surg; 2020 Apr; 230(4):709-717. PubMed ID: 32032721
[TBL] [Abstract][Full Text] [Related]
12. The effect of small interfering RNA (siRNA) against the Bcl-2 gene on apoptosis and chemosensitivity in a canine mammary gland tumor cell line.
Nagamatsu K; Tsuchiya F; Oguma K; Maruyama H; Kano R; Hasegawa A
Res Vet Sci; 2008 Feb; 84(1):49-55. PubMed ID: 17537469
[TBL] [Abstract][Full Text] [Related]
13. Characterization of MDCK cells and evaluation of their ability to respond to infectious and non-infectious stressors.
Capellini FM; Vencia W; Amadori M; Mignone G; Parisi E; Masiello L; Vivaldi B; Ferrari A; Razzuoli E
Cytotechnology; 2020 Feb; 72(1):97-109. PubMed ID: 31802289
[TBL] [Abstract][Full Text] [Related]
14. Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines.
Gray M; Turnbull AK; Meehan J; Martínez-Pérez C; Kay C; Pang LY; Argyle DJ
Front Vet Sci; 2020; 7():439. PubMed ID: 32851022
[TBL] [Abstract][Full Text] [Related]
15. PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1.
Zhang Z; Yang A; Chaurasiya S; Park AK; Kim SI; Lu J; Olafsen T; Warner SG; Fong Y; Woo Y
Mol Ther Oncolytics; 2022 Mar; 24():331-339. PubMed ID: 35118191
[TBL] [Abstract][Full Text] [Related]
16. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity.
Kim SI; Park AK; Chaurasiya S; Kang S; Lu J; Yang A; Sivanandam V; Zhang Z; Woo Y; Priceman SJ; Fong Y; Warner SG
Mol Cancer Ther; 2021 Jan; 20(1):173-182. PubMed ID: 33262221
[TBL] [Abstract][Full Text] [Related]
18. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462
[TBL] [Abstract][Full Text] [Related]
19. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Akt Activity Promotes Virus Entry and Predicts Efficacy of Novel Chimeric Orthopoxvirus in Triple-Negative Breast Cancer.
Choi AH; O'Leary MP; Lu J; Kim SI; Fong Y; Chen NG
Mol Ther Oncolytics; 2018 Jun; 9():22-29. PubMed ID: 29988465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
